Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Human Vaccines & Immunotherapeutics|November 27, 2014
Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivoSuvi Lappalainen, Ana Ruth Pastor, Kirsi Tamminen, et al.
Vaccine|October 6, 2019
Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirusSuvi Heinimäki, Minna M Hankaniemi, Amir-Babak Sioofy-Khojine, et al.
Journal of Virological Methods|May 24, 2011
Production and characterization of virus-like particles and the P domain protein of GII.4 norovirusTiia Koho, Leena Huhti, Vesna Blazevic, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 15, 2015
His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface displayTiia Koho, Teemu O Ihalainen, Marie Stark, et al.
Vaccine|September 1, 2019
A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccineMinna M Hankaniemi, Virginia M Stone, Amir-Babak Sioofy-Khojine, et al.
Antiviral Research|September 7, 2019
Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccineMinna M Hankaniemi, Virginia M Stone, Tanja Andrejeff, et al.
Frontiers in Immunology|October 24, 2022
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccineIsabel Leroux-Roels, Cathy Maes, Jasper Joye, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 22, 2019
Early-life exposure to common virus infections did not differ between coeliac disease patients and controlsKärt Simre, Oivi Uibo, Aleksandr Peet, et al.
Cancer Research|September 17, 2005
Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologueLeena Karenko, Sonja Hahtola, Suvi Päivinen, et al.
Pageof 6